Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 16 items.
… Reason Affected products Affected Products LUCIRA CHECKIT COVID-19 TEST KIT Reason "Copan", the manufacturer of Floqswabs, is … lot number 2027877. This swab is a component in the lucira Covid-19 test kit Affected products LUCIRA CHECKIT COVID-19 …
RecallHealth product recall | 2021-10-22
… (the Canadian importer and distributor) is distributing COVID-19 Vaccine Moderna doses directly to vaccination locations … and public health authorities. Key messages The COVID-19 Vaccine Moderna (mRNA-1273 SARS-CoV-2 vaccine) …
AlertHealth professional risk communication | 2021-02-22
… (POUs). Pfizer is initially distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination locations … Key messages On December 9, 2020, Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02509210) was …
AlertHealth professional risk communication | 2020-12-12
… Reason Affected products Affected Products Spartan Cube Covid-19 System - Computer Spartan Cube Covid-19 System - Cube Reason Issue 1: ""power button"" on …
RecallHealth product recall | 2020-05-15
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered together, … treatment of mild to moderate coronavirus disease 2019 (COVID-19), confirmed by direct SARS-CoV-2 viral testing, in …
AlertHealth professional risk communication | 2021-07-30
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of adults … patients 12 years of age or older with mild to moderate COVID-19, who weigh at least 40 kg and who are at high risk …
AlertHealth professional risk communication | 2020-12-18
… Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Care Professional: Please be aware of the following: Janssen-Ortho Inc. and Aventis Pharma Inc. (collectively, … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, OntarioM3C 1L9 Call toll-free at …
AlertHealth professional risk communication | 2004-12-21
… Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … ® Dear Pharmacist: Please be aware of the following: Janssen-Ortho Inc. and Aventis Pharma Inc. (collectively, … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Call toll-free …
AlertHealth professional risk communication | 2004-12-21
… Images This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … powder for Injectable Prolonged-Release Suspension Janssen-Ortho, in cooperation with Health Canada, would like … Janssen-Ortho Inc. Medical Information Department 19 Green Belt Drive Toronto, Ontario M3C 1L9 Telephone: …
AlertHealth professional risk communication | 2010-05-25
… Starting date: May 19, 2015 Posting date: June 15, 2015 Type of communication: … Products CELLSEARCH Circulating Tumor Cell Kit Reason Janssen Diagnostics LLC has received reports from customers … Model or catalog number 7900001 Companies Manufacturer Janssen Diagnostics, LLC 700 US Hwy 202 South Paritan 08869 …
RecallHealth product recall | 2015-06-15
… effective August 7, 2000. PREPULSID, marketed by Janssen-Ortho Inc., is a prescription drug indicated for the … outweigh the risk of serious cardiac adverse events. Janssen-Ortho Inc. has indicated to Health Canada that it … The Special Access Programme is prepared to authorize Janssen- Ortho to release PREPULSID for these patients. …
AlertHealth professional risk communication | 2000-05-30
… RA-17000390 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … Dementia Trials Dear Healthcare Professional: Janssen-Ortho Inc., following discussions with Health Canada, … USA-63 1% (5/462) 1% (2/163) BEL-14 0% (0/20) 0% (0/19) Total 4% (29/764) 2% (7/466) Four patients died in the …
AlertHealth professional risk communication | 2002-10-11
… RA-170001355 This is duplicated text of a letter from Janssen-Ortho . Contact the company for a copy of any … Professional, Following discussions with Health Canada, Janssen-Ortho Inc. would like to update you on important new … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Or call toll …
AlertHealth professional risk communication | 2006-11-23
… Starting date: October 15, 2009 Posting date: October 19, 2009 Type of communication: Dear Healthcare Professional … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc. Contact the company for a copy of any … Dear Health Care Professional, Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19
… RA-170001865 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … * (darunavir) and hepatotoxicity Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in cooperation with Health … a division of Janssen-Ortho Inc. Drug Safety Department 19 Green Belt Drive Toronto, ON M3C 1L9 Tel: 800-567-3331 or …
AlertHealth professional risk communication | 2008-05-15